Affiliation:
1. Osaka University Graduate School of Medicine
2. Osaka University
3. Chugai Pharmaceutical Co. Ltd
4. Chugai Pharmaceutical Co. Ltd.
Abstract
Abstract
Patients with autoimmune vasculitis present with diverse organ-threatening symptoms, but the underlying immunological basis of the clinical heterogeneity remains poorly understood. We conducted single-cell transcriptome and surface proteome analyses using CITE-seq on 109,350 peripheral blood mononuclear cells (PBMCs) and CyTOF on 737,794 PBMCs from newly-onset patients with microscopic polyangiitis (MPA) and age-matched healthy donors. Increased proportions of activated CD14+ monocytes, CD14+ monocytes expressing interferon signature genes (ISGs), cytotoxic CD8+ T cells, and killer immunoglobulin-like receptor (KIR)+ CD8+ T cells were distinctive features of MPA. Patient-specific analysis classified MPA into two groups characterized by CD14+ monocyte signature gene expression (MPA-MONO) and ISG expression (MPA-IFN). The MPA-MONO group was characterized by a high proportion of activated CD14+ monocytes, which persisted before and after immunosuppressive therapy. Patients in this group had a high rate of relapse and were clinically defined by increased monocyte ratio in the total PBMC count and high C-reactive protein titers. The MPA-IFN group was characterized by a high proportion of ISG+ CD14+ monocytes, which significantly decreased following treatment. Patients in this group showed good response to immunosuppressive therapy and were clinically defined by high serum interferon-alpha concentrations, renal symptoms, and high myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) titers. Our findings identify the immunological phenotypes of MPA and provide clinical recommendations for personalized treatment based on accurate prognostic prediction.
Publisher
Research Square Platform LLC
Reference42 articles.
1. ANCA small-vessel vasculitis;Falk RJ;J Am Soc Nephrol,1997
2. Small-vessel vasculitis;Jennette JC;N Engl J Med,1997
3. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis;Yates M;Annals of the rheumatic diseases,2016
4. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro;Falk RJ;Proc Natl Acad Sci U S A,1990
5. Porges, A. J. et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. Journal of immunology (Baltimore, Md.: 1950) 153, 1271–1280 (1994).